Development of plasma cell tumors during treatment of multiple myeloma

被引:6
|
作者
Vaiopoulos, G [1 ]
Viniou, N [1 ]
Plata, E [1 ]
Konstantopoulos, K [1 ]
Andreopoulos, A [1 ]
Rombos, Y [1 ]
Meletis, J [1 ]
Loukopoulos, D [1 ]
Yataganas, X [1 ]
机构
[1] UNIV ATHENS,LAIKO GEN HOSP,SCH MED,DEPT INTERNAL MED 1,GR-11527 ATHENS,GREECE
关键词
multiple myeloma; plasmacytoma; alpha-interferon; computerized tomography;
D O I
10.1007/s002770050178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma cell tumors (plasmacytomas-PCT) of the bone, or extramedullary PCT, may be diagnosed in patients with or without the diagnostic criteria for systemic multiple myeloma (MM). The reason for the local development of these tumors is not clear. Recent reports emphasize the contribution of CT and MRI in the detection of bone lesions and their expansion into the soft tissues. We report the development of PCT in nine patients with MM under maintenance treatment with alpha-IFN, of whom six had no evidence of systemic relapse and three had indications of early relapse. The PCT were located in the pelvis (4), thoracic (3), cervical (1), and lumbar (2) spine and in 8/9 cases were not demonstrable on plain X-rays. These observations suggest that frequent screening with advanced imaging techniques may detect local disease expansion in asymptomatic patients. Early application of radiochemotherapy may improve prognosis.
引用
收藏
页码:317 / 320
页数:4
相关论文
共 50 条
  • [1] Dendritic cell counts and their subsets during treatment of multiple myeloma
    Kovarova, L.
    Buchler, T.
    Pour, L.
    Zahradova, L.
    Ocadlikova, D.
    Svobodnik, A.
    Penka, M.
    Vorlicek, J.
    Hajek, R.
    NEOPLASMA, 2007, 54 (04) : 297 - 303
  • [2] Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide
    Mathias Witzens
    Thomas Moehler
    Kai Neben
    Stefan Fruehauf
    Wolfgang Hartschuh
    Anthony D. Ho
    Hartmut Goldschmidt
    Annals of Hematology, 2004, 83 : 467 - 470
  • [3] Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide
    Witzens, M
    Moehler, T
    Neben, K
    Fruehauf, S
    Hartschuh, W
    Ho, AD
    Goldschmidt, H
    ANNALS OF HEMATOLOGY, 2004, 83 (07) : 467 - 470
  • [4] Plasma cell P170 expression and response to treatment in multiple myeloma
    Patriarca, F
    Melli, C
    Damiani, D
    Michieli, M
    Michelutti, A
    Cavo, M
    Baccarani, M
    HAEMATOLOGICA, 1996, 81 (03) : 232 - 237
  • [5] Multiple myeloma and secondary plasma cell leukemia
    dos Santos, Vitorino Modesto
    Melim, Sandro Pinheiro
    de Faria, Priscilla Souza
    Passini, Viviane Vieira
    Duarte, Mayza Lemes
    Casasanta, Renata Athayde
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2016, 57 (02) : 837 - 839
  • [6] Multiple myeloma: abdominal pain during treatment
    Lechner-Tschoep, K.
    DiGioia, D.
    Pastore, A.
    Johnson, T.
    Stemmler, H. J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (03) : 87 - 88
  • [7] Feasibility of exercise during treatment for multiple myeloma
    Coleman, EA
    Coon, S
    Hall-Barrow, J
    Richards, K
    Gaylor, D
    Stewart, B
    CANCER NURSING, 2003, 26 (05) : 410 - 419
  • [8] Successful Treatment of Extramedullary Tumors with Low-dose Thalidomide in Patients with Multiple Myeloma
    Yasuda, Hajime
    Ando, Jun
    Sato, Eriko
    Inagaki, Naoko
    Aritaka, Nanae
    Komatsu, Norio
    Hirano, Takao
    INTERNAL MEDICINE, 2010, 49 (23) : 2617 - 2620
  • [9] Plasma cell maturity as a predictor of prognosis in multiple myeloma
    Iriyama, Noriyoshi
    Miura, Katsuhiro
    Hatta, Yoshihiro
    Uchino, Yoshihito
    Kurita, Daisuke
    Takahashi, Hiromichi
    Sakagami, Hitomi
    Sakagami, Masashi
    Kobayashi, Yujin
    Nakagawa, Masaru
    Ohtake, Shimon
    Iizuka, Yoshikazu
    Takei, Masami
    MEDICAL ONCOLOGY, 2016, 33 (08)
  • [10] Demonstration of changes in plasma cell subsets in multiple myeloma
    Ayliffe, Michael John
    Davies, Faith Elizabeth
    de Castro, David
    Morgan, Gareth John
    HAEMATOLOGICA, 2007, 92 (08) : 1135 - 1138